4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-036499
Chief Medical Officer sold 17,500 shares at an average $18.78 ($328,653)
- Chief Medical Officer acquired 4,617 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2019-06-10 | Option exercise | +711 | $5.28 | $3,754 | 711 | D |
| Ho Carole Chief Medical Officer | 2019-06-10 | Sale | −711 | $18.62 | $13,239 | 0 | D |
| Ho Carole Chief Medical Officer | 2019-06-10 | Option exercise | +3,906 | $5.28 | $20,624 | 3,906 | D |
| Ho Carole Chief Medical Officer | 2019-06-10 | Sale | −3,906 | $18.81 | $73,472 | 0 | D |
| Ho Carole Chief Medical Officer | 2019-06-10 | Sale | −12,883 | $18.78 | $241,943 | 90,923 | I |
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2019-06-10 | Option exercise · Stock Option (right to buy) | −711 | 95,169 | D | ||
| Ho Carole Chief Medical Officer | 2019-06-10 | Option exercise · Stock Option (right to buy) | −3,906 | 82,033 | D | ||
| Open-market sales · 17,500 sh · avg $18.78 · $328,653 | |||||||
Loading xslF345X03/doc4.xml…